Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $5

Benzinga · 2d ago
Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $4 to $5.